Hepcidin in tumor‐related iron deficiency anemia and tumor‐related anemia of chronic disease: pathogenic mechanisms and diagnosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives: Anemia is a common hematological abnormality in patients with cancer. Iron deficiency anemia (IDA) and anemia of chronic disease (ACD) are the most prevalent, both characterized by hypochromic microcytic anemia and low serum iron (SI). Their differential diagnosis is difficult in clinical practice, hampering their treatment. Our objective was to evaluate the use of hepcidin to discriminate tumor‐related IDA and ACD and to investigate the mechanism of action of hepcidin in these anemias. Methods: Blood samples were collected at Jiangsu Cancer Hospital. Patients were divided into IDA and ACD groups by Prussian blue staining of bone marrow smears. Serum hepcidin was measured by enzyme‐linked immunosorbent assay. SI, total iron‐binding capacity (TIBC), transferrin saturation (TSAT), interleukin‐6 (IL‐6), and tumor necrosis factor α (TNF‐α) also determined in this study. Results: Areas under the curve on receiver operating characteristic analysis indicated the diagnostic sensitivity and specificity of hepcidin to be better than those of SI, TIBC, and TSAT. In ACD, hepcidin was correlated positively with IL‐6 (r = 0.81, P < 0.01) and negatively with SI (r = −0.78, P < 0.01). In IDA, no significant relationship between IL‐6 and hepcidin was found (r = −0.20, P = 0.17), but hepcidin decreased with decreasing quartiles of SI (r = 0.89, P < 0.01). SI was positively correlated with hemoglobin (r = 0.89, P < 0.01; r = 0.84, P < 0.01) in both groups. Conclusions: Hepcidin is a promising serological marker for the differential diagnosis of tumor‐related ACD and IDA, clarifying the pathogenesis of these anemias and guiding corrective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“In 2000, hepcidin was first identified in serum (13) and urine (14) as an antimicrobial peptide mainly produced in the liver.”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“The possible explanation is that hepcidin expression is stimulated by acute-phase II response cytokines like IL-6, while acute-phase I response cytokines such as IL-1a, IL-1b, TNF-a, and TNF-b show no similar effect (27).”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
ABDEL-KHALEK, M. A., EL-BARBARY, A. M., ESSA, S. A.-M., & GHOBASHI, A. S. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110339 · Cited by 68 · cited 1×
“Hepcidin has been confirmed as a biochemical marker for the differentiation of IDA and ACD in several diseases, including coronary artery atherosclerosis (23), rheumatoid arthritis (19), and Crohn’s disease (24), and in hospitalized geriatric patients (25).”
Background
Research works printed but not linked: 23
- 10.1016/j.ejca.2004.06.019 · DOI · Paper page
- 10.1159/000088282 · DOI
- 10.2217/fon.11.24 · DOI
- 10.6004/jnccn.2012.0064 · DOI · Paper page
- 10.2146/ajhp060601 · DOI
- 10.2146/ajhp110039 · DOI
- 10.1186/cc2825 · DOI
- 10.2147/CMAR.S45236 · doi:10.2147/cmar.s45236
- 10.1503/cmaj.090470 · DOI · Paper page
- Kenneth K, 2010, Williams Hematology, 617
- 10.1093/clinchem/48.7.1066 · DOI · Paper page
- 10.1373/49.10.1573 · DOI · Paper page
- 10.1136/gut.2010.214312 · DOI · Paper page
- 10.1172/JCI67225 · DOI · Paper page
- 10.1182/blood-2008-12-195651 · DOI · Paper page
- 10.1002/art.30623 · DOI · Paper page
- World Health Organisation, 1968, Nutritional Anemia: Report of WHO Scientific Group
- Watanabe K, 1978, Staining for iron, Rinsho Byori, 34, 102
- 10.1007/s10238-010-0102-9 · DOI
- 10.1097/01.mib.0000235097.86360.04 · DOI · Paper page
- 10.5402/2012/567491 · DOI
- 10.1002/ajh.23110 · DOI · Paper page
- 10.1007/s12032-007-9000-8 · DOI
Cited by
Pasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Hepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417
Urbanski, G., Chabrun, F., Lavigne, C., Lacout, C., Delattre, E., Reynier, P., & Requin, J. (2024) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcad218 · Cited by 12
Metadata
- Authors
- Shu, T., Jing, C., Lv, Z., Xie, Y., Xu, J., & Wu, J.
- Venue
- European Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-07-31
- Volume
- 94
- Issue
- 1
- Pages
- 67-73
- ISSN
- 0902-4441 (ISSN-L)
- 1600-0609
- OpenAlex
- W2024163342
- Cited by
- 44
- References
- 5
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.